This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with Stage IIa-IIIa Breast Cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery and have fewer side effects.
Principal Investigator: Mini Elnaggar, MD
|Full Protocol Title||Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction|
Main Campus - Jefferson Highway
|Sponsor||Alliance for Clinical Trials in Oncology|
|Change in Care||Participating may change your care|